PsyBio Therapeutics Corp. (PSYBF)

Market Cap	133.00 -100.0%
Revenue (ttm)	n/a
Net Income	-1.90M
EPS	-0.02
Shares Out	132.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	177,240
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-900.66
RSI	43.74
Earnings Date	n/a

About PsyBio Therapeutics

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: PSYBF